Home Cart Sign in  
Chemical Structure| 68401-82-1 Chemical Structure| 68401-82-1

Structure of Ceftizoxime sodium
CAS No.: 68401-82-1

Chemical Structure| 68401-82-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Ceftizoxime Sodium is third generation cephalosporin effective against Gram-negative and Gram-positive bacteria. It binds penicillin-binding proteins (PBPs) and inhibits the bacterial cell wall synthesis.

Synonyms: SKF-88373

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Ceftizoxime sodium

CAS No. :68401-82-1
Formula : C16H16N5NaO8S
M.W : 461.38
SMILES Code : O=C([O-])C(N1[C@]([H])([C@@H](C1=O)NC(/C(C2=CC=CO2)=N\OC)=O)SC3)=C3CO/C(N)=N/O.[Na+]
Synonyms :
SKF-88373
MDL No. :MFCD01682036

Safety of Ceftizoxime sodium

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT03098485 Microbiota An... More >>ti-bacterial Agents Less << Not Applicable Active, not recruiting June 30, 2019 United States, Missouri ... More >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Less <<
NCT00194532 Urinary Tract Infection Not Applicable Completed - United States, Florida ... More >> University of Miami Miller School of Medicine Miami, Florida, United States, 33136 United States, Washington University of Washington Seattle, Washington, United States, 98195 Less <<
NCT00194532 - Completed - -
NCT03729258 Sinusitis Sin... More >>usitis, Acute Rhinosinusitis Rhinosinusitis Acute Sinus Infection Less << Phase 3 Not yet recruiting September 1, 2019 Turkey ... More >> Bakırköy Dr. Sadi Konuk Training and Research Hospital Not yet recruiting Istanbul, Turkey Contact: İbrahim Sayın, Assoc Prof Dr          Contact       dribrahimsayin@yahoo.com Less <<
NCT03491748 Healthy Volunteers Phase 1 Recruiting May 2019 Australia, Victoria ... More >> Nucleus Network Recruiting Melbourne, Victoria, Australia, 3004 Less <<
NCT02099240 Osteomyelitis Early Phase 1 Recruiting September 2019 United States, Kentucky ... More >> University of Louisville Recruiting Louisville, Kentucky, United States, 40202 Contact: Julio A Ramirez, MD    502-852-1148    jarami01@louisville.edu    Contact: David Seligson, MD    502-852-0923    d0seli01@louisville.edu    Sub-Investigator: Forest Arnold, DO          Sub-Investigator: Timothy Wiemkwn, PhD          Sub-Investigator: Robert Kelley, PhD          Sub-Investigator: James Summersgill, PhD          Sub-Investigator: Ruth Carrico, PhD          Sub-Investigator: Julie Harting, PharmD          Sub-Investigator: Paula Peyrani, MD          Principal Investigator: David Seligson, MD          Sub-Investigator: Craig Roberts, MD          Principal Investigator: Julio Ramirez, MD Less <<
NCT01347593 Caesarean Phase 4 Completed - Sudan ... More >> Soba Hospital Khartoum, Sudan, 249 Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.17mL

0.43mL

0.22mL

10.84mL

2.17mL

1.08mL

21.67mL

4.33mL

2.17mL

References

 

Historical Records

Categories